Ban on private labs in Mumbai may hit COVID-19 battle

The testing rate is likely to slow down, report Pavan Lall and Sohini Das.   IMAGE: A man reacts as a doctor takes a swab from his nose to test at Mukund Nagar in Mumbai's Dharavi area.......

Covid-19: Mumbai to ramp up testing to 4,000 a day

Mumbai, with an estimated population of nearly 20 million, has been testing 1,200-1,400 people per day. Delay in the delivery of rapid antibody test kits has forced the municipal corporation......

Modi sounds bugle for Mumbai civic polls, says no dearth of funds for city

Mumbai's civic body plays a key role in development of the metropolis and while there was no dearth of funds for the city, it is important budgeted money is spent to achieve stated objectives and......

BMC must ensure citizens are safe from Omicron: Bombay HC

The Bombay high court on Monday said the Brihanmumbai Municipal Corporation must not leave any stone unturned in ensuring people of the metropolis remained safe from the rapidly rising number of......

Metropolis Healthcare's Rs 1,200-cr IPO to open on Apr 3

The offering comprises secondary sale of 13.68 million shares, constituting 27.3 per cent stake. The price band for the IPO is Rs 877 to Rs 880 per share. Diagnostics company Metropolis......

GST cut on drugs, medical devices to help patients

The government's move to cut GST on medicines and medical devices while exempting lifesaving drugs from the levy is a bold step that will bring direct relief to patients and families while......

Amazon's entry into healthcare a headwind but diagnostic stocks attractive

The news that Amazon India has launched diagnostic services in select metro cities in partnership with the unlisted Orange Health Labs has led to a look at the competitive intensity in healthcare......

Steady heartbeat of growth in diagnostics stock keeps sector pulsing

The stocks of diagnostic service providers have been standout performers within the healthcare sector over the past year, posting returns between 16 and 80 per cent. In comparison, the Nifty 50 saw......